Literature DB >> 2246253

Identification and characterization of heparan sulfate-binding proteins from human lung carcinoma cells.

M E Bilozur1, C Biswas.   

Abstract

The heparan sulfate proteoglycan/heparin-binding proteins of the human lung carcinoma cell line LX-1 have been identified, partially purified, and characterized. Analysis of the binding of [3H]heparin to membranes isolated from LX-1 cells indicated the presence of two classes of binding sites, with Kd values of approximately 2 x 10(-10) and 4 x 10(-8) M and corresponding Bmax values of 1 x 10(5) and 2 x 10(7) binding sites/cell. Binding was also observed with isolated heparan sulfate chains and with intact heparan sulfate proteoglycan isolated from two different cell types. With each ligand, binding was inhibited by addition of unlabeled heparin. The binding proteins were extracted from LX-1 cell membranes in detergent solution, and two size classes of binding proteins were identified by overlaying transblots of electrophoretically separated proteins with radioactive ligands. These two classes of binding proteins were shown to contain doublets with estimated molecular masses of approximately 16 kDa (HSBP1A and HSBP1B) and approximately 32 kDa (HSBP2A and HSBP2B). The proteins were partially purified by heparin-Sepharose chromatography and shown to bind heparin and heparan sulfate proteoglycan. By amino acid composition, N-terminal amino acid sequence, and reactivity with antibody, HSBP1A was shown to be very similar to histone 2B; HSBP1B may also be related to histone 2A. HSBP2A and HSBP2B, however, did not react with antibodies to the major histones and had compositions different from one another and from HSBP1.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2246253

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Genogroup II noroviruses efficiently bind to heparan sulfate proteoglycan associated with the cellular membrane.

Authors:  Masaru Tamura; Katsuro Natori; Masahiko Kobayashi; Tatsuo Miyamura; Naokazu Takeda
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

2.  The heparin-binding lectin from ovine placenta: purification and identification as histone H4.

Authors:  A L Ambrosio; M M Iglesias; C Wolfenstein-Todel
Journal:  Glycoconj J       Date:  1997-11       Impact factor: 2.916

3.  Histones and basic polypeptides activate Ca2+/cation influx in various cell types.

Authors:  A Gamberucci; R Fulceri; P Marcolongo; W F Pralong; A Benedetti
Journal:  Biochem J       Date:  1998-04-15       Impact factor: 3.857

4.  Heparin inhibits the binding of basic fibroblast growth factor to cultured human aortic smooth-muscle cells.

Authors:  F Bono; P Rigon; I Lamarche; P Savi; V Salel; J M Herbert
Journal:  Biochem J       Date:  1997-09-15       Impact factor: 3.857

5.  Sulfated polyanions block Chlamydia trachomatis infection of cervix-derived human epithelia.

Authors:  F R Zaretzky; R Pearce-Pratt; D M Phillips
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

6.  In vitro interactions of extracellular histones with LDL suggest a potential pro-atherogenic role.

Authors:  Alan D Pemberton; Jeremy K Brown
Journal:  PLoS One       Date:  2010-03-25       Impact factor: 3.240

7.  Antibodies to a cell surface histone-like protein protect against Histoplasma capsulatum.

Authors:  Joshua D Nosanchuk; Judith N Steenbergen; Li Shi; George S Deepe; Arturo Casadevall
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

8.  Pathway for polyarginine entry into mammalian cells.

Authors:  Stephen M Fuchs; Ronald T Raines
Journal:  Biochemistry       Date:  2004-03-09       Impact factor: 3.162

9.  Extracellularly occurring histone H1 mediates the binding of thyroglobulin to the cell surface of mouse macrophages.

Authors:  K Brix; W Summa; F Lottspeich; V Herzog
Journal:  J Clin Invest       Date:  1998-07-15       Impact factor: 14.808

10.  Surface architecture of histoplasma capsulatum.

Authors:  Allan J Guimarães; Mariana D de Cerqueira; Joshua D Nosanchuk
Journal:  Front Microbiol       Date:  2011-11-18       Impact factor: 5.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.